| 【公司研究】青島啤酒（168 HK) – 业绩超预期；4Q20高端化提速 |
| 【公司研究】中国人寿 (2628 HK) – 新业务价值增速符合预期 |
| 【Company Research】Simcere Pharmaceutical Group (2096 HK) – Increasing contribution from innovative products |
| 【Company Research】Meituan (3690 HK) – Reinvestment on new initiatives |
| 【Company Research】Antengene Corporation Limited (6996 HK) – Innovative and highly-differentiated pipelines focusing on oncology |
| 【Company Research】Kintor Pharmaceutical (9939 HK) – Fast clinical progress for Proxalutamide and other core assets |
| 【Company Research】InnoCare Pharma (9969 HK) – Entering into commercial stage |
| 【Company Research】China East Education (667 HK) – YTD number of new students enrolled exceed pre-pandemic level |
| 【Company Research】Haidilao (6862 HK) – Gradual recovery and store expansion intact |
| 【Company Research】Q Technology (1478 HK) – Stronger CCM outlook in 2021; Raise TP to HK$23.0 |
公司地址：香港中环花园道三号冠君大厦45-46楼
电话：（852）3900-0888 传真：（852）3761-8788
招银国际版权所有 Copyright © 2019-2026 CMB International Capital Corporation Limited. All rights reserved.
